Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
69.44
+0.14 (0.20%)
At close: Mar 31, 2025, 4:00 PM
69.41
-0.03 (-0.05%)
After-hours: Mar 31, 2025, 8:00 PM EDT
Novo Nordisk (NVO) Operating Income by Segment
History
| Date | Diabetes and Obesity Care | Rare Disease |
|---|---|---|
| Dec 31, 2024 | 17.74B | 86.14M |
| Sep 30, 2024 | 16.35B | 91.84M |
| Jun 30, 2024 | 15.42B | 70.02M |
| Mar 31, 2024 | 14.82B | 379.99M |
| Dec 31, 2023 | 13.84B | 410.00M |
| Sep 30, 2023 | 12.58B | 322.19M |
| Jun 30, 2023 | 11.39B | 577.00M |
| Mar 31, 2023 | 10.45B | 762.75M |
| Dec 31, 2022 | 9.36B | 1.03B |
| Sep 30, 2022 | 8.65B | 1.26B |
| Jun 30, 2022 | 7.94B | 1.29B |
| Mar 31, 2022 | 7.43B | 1.30B |
| Dec 31, 2021 | 6.88B | 1.27B |
| Sep 30, 2021 | 6.50B | 1.31B |
| Jun 30, 2021 | 6.04B | 1.43B |
| Mar 31, 2021 | 5.94B | 1.40B |
| Dec 31, 2020 | 6.08B | 1.44B |
| Sep 30, 2020 | 6.06B | 1.55B |
| Jun 30, 2020 | 6.16B | 1.48B |
| Mar 31, 2020 | 6.15B | 1.43B |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.